NEW YORK, Nov. 16, 2016 -- The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that trading was halted today in DryShips Inc. (Nasdaq:DRYS) at 08:49:11 Eastern Time for "additional information requested" from the company at a last price of $73.00.
Trading will remain halted until DryShips Inc. has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Nasdaq Media Contact: Christine Barna 646 441 5310 [email protected]


Nvidia and Groq Strike Strategic AI Inference Licensing Deal
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FDA Approves Mitapivat for Anemia in Thalassemia Patients
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



